Lowe Brockenbrough & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.66M | Sell |
30,639
-722
| -2% | -$160K | 0.33% | 73 |
|
|
2025
Q4 | $7.17M | Sell |
31,361
-370
| -1% | -$84.3K | 0.35% | 69 |
|
|
2025
Q3 | $7.35M | Sell |
31,731
-104
| -0.3% | -$21.2K | 0.38% | 66 |
|
|
2025
Q2 | $5.91M | Buy |
31,835
+1,303
| +4% | +$242K | 0.33% | 75 |
|
|
2025
Q1 | $6.4M | Sell |
30,532
-333
| -1% | -$64.7K | 0.42% | 64 |
|
|
2024
Q4 | $5.48M | Sell |
30,865
-409
| -1% | -$75.2K | 0.35% | 71 |
|
|
2024
Q3 | $6.18M | Buy |
31,274
+4,299
| +16% | +$802K | 0.39% | 66 |
|
|
2024
Q2 | $4.63M | Sell |
26,975
-1,264
| -4% | -$209K | 0.31% | 80 |
|
|
2024
Q1 | $5.14M | Sell |
28,239
-5,300
| -16% | -$913K | 0.35% | 77 |
|
|
2023
Q4 | $5.2M | Buy |
33,539
+1,610
| +5% | +$235K | 0.4% | 71 |
|
|
2023
Q3 | $4.76M | Sell |
31,929
-4,825
| -13% | -$708K | 0.37% | 77 |
|
|
2023
Q2 | $4.95M | Buy |
36,754
+29
| +0.1% | +$4.25K | 0.37% | 75 |
|
|
2023
Q1 | $5.85M | Buy |
36,725
+2,263
| +7% | +$346K | 0.47% | 62 |
|
|
2022
Q4 | $5.57M | Sell |
34,462
-2,548
| -7% | -$391K | 0.48% | 62 |
|
|
2022
Q3 | $4.97M | Buy |
37,010
+321
| +0.9% | +$46.1K | 0.48% | 63 |
|
|
2022
Q2 | $5.62M | Sell |
36,689
-166
| -0.5% | -$25.4K | 0.49% | 65 |
|
|
2022
Q1 | $5.97M | Sell |
36,855
-1,409
| -4% | -$205K | 0.44% | 68 |
|
|
2021
Q4 | $5.18M | Hold |
38,264
| – | – | 0.38% | 75 |
|
|
2021
Q3 | $4.13M | Sell |
38,264
-5,275
| -12% | -$603K | 0.32% | 82 |
|
|
2021
Q2 | $4.9M | Sell |
43,539
-155
| -0.4% | -$17.5K | 0.44% | 65 |
|
|
2021
Q1 | $4.73M | Sell |
43,694
-221
| -0.5% | -$23.6K | 0.46% | 65 |
|
|
2020
Q4 | $4.71M | Sell |
43,915
-625
| -1% | -$60.1K | 0.51% | 63 |
|
|
2020
Q3 | $3.9M | Buy |
44,540
+2
| +0% | +$188 | 0.49% | 65 |
|
|
2020
Q2 | $4.37M | Buy |
44,538
+413
| +0.9% | +$36.4K | 0.59% | 57 |
|
|
2020
Q1 | $3.36M | Sell |
44,125
-777
| -2% | -$66.2K | 0.55% | 59 |
|
|
2019
Q4 | $3.98M | Sell |
44,902
-170
| -0.4% | -$14.1K | 0.49% | 64 |
|
|
2019
Q3 | $3.41M | Buy |
45,072
+50
| +0.1% | +$3.43K | 0.46% | 67 |
|
|
2019
Q2 | $3.27M | Hold |
45,022
| – | – | 0.45% | 70 |
|
|
2019
Q1 | $3.63M | Buy |
45,022
+600
| +1% | +$49.1K | 0.51% | 64 |
|
|
2018
Q4 | $4.09M | Sell |
44,422
-350
| -0.8% | -$30.8K | 0.67% | 52 |
|
|
2018
Q3 | $4.24M | Sell |
44,772
-475
| -1% | -$45K | 0.59% | 58 |
|
|
2018
Q2 | $4.19M | Buy |
45,247
+395
| +0.9% | +$38.6K | 0.62% | 57 |
|
|
2018
Q1 | $4.25M | Sell |
44,852
-835
| -2% | -$91.7K | 0.63% | 55 |
|
|
2017
Q4 | $4.42M | Sell |
45,687
-340
| -0.7% | -$32K | 0.63% | 54 |
|
|
2017
Q3 | $4.09M | Sell |
46,027
-1,281
| -3% | -$97.5K | 0.63% | 58 |
|
|
2017
Q2 | $3.43M | Sell |
47,308
-430
| -0.9% | -$28.9K | 0.54% | 63 |
|
|
2017
Q1 | $3.11M | Buy |
47,738
+2,479
| +5% | +$156K | 0.5% | 65 |
|
|
2016
Q4 | $2.83M | Sell |
45,259
-875
| -2% | -$53.4K | 0.47% | 66 |
|
|
2016
Q3 | $2.91M | Sell |
46,134
-2,388
| -5% | -$155K | 0.5% | 67 |
|
|
2016
Q2 | $3M | Sell |
48,522
-4,180
| -8% | -$255K | 0.52% | 67 |
|
|
2016
Q1 | $3.01M | Sell |
52,702
-2,170
| -4% | -$121K | 0.52% | 66 |
|
|
2015
Q4 | $3.25M | Sell |
54,872
-66,133
| -55% | -$3.81M | 0.55% | 63 |
|
|
2015
Q3 | $6.58M | Sell |
121,005
-1,255
| -1% | -$81.7K | 1.15% | 25 |
|
|
2015
Q2 | $8.21M | Sell |
122,260
-7,327
| -6% | -$478K | 1.32% | 17 |
|
|
2015
Q1 | $7.59M | Sell |
129,587
-61
| -0% | -$3.69K | 1.2% | 22 |
|
|
2014
Q4 | $8.48M | Sell |
129,648
-6,645
| -5% | -$419K | 1.35% | 17 |
|
|
2014
Q3 | $7.87M | Sell |
136,293
-575
| -0.4% | -$31.9K | 1.26% | 21 |
|
|
2014
Q2 | $7.72M | Sell |
136,868
-5,418
| -4% | -$284K | 1.23% | 21 |
|
|
2014
Q1 | $7.31M | Sell |
142,286
-1,840
| -1% | -$93K | 1.22% | 24 |
|
|
2013
Q4 | $7.61M | Sell |
144,126
-4,715
| -3% | -$232K | 1.26% | 24 |
|
|
2013
Q3 | $6.66M | Buy |
148,841
+6,398
| +4% | +$284K | 1.21% | 28 |
|
|
2013
Q2 | $5.89M | Buy |
+142,443
| New | +$6.23M | 1.09% | 38 |
|
Other funds holding ABBV
VCM
VPM
Lowe Brockenbrough & Co's ABBV Position: Q1 2026 in Review
Lowe Brockenbrough & Co reduced its AbbVie (ABBV) stake by 2.3% in Q1 2026, selling an estimated $160K and leaving 30,639 shares worth $6.66M. The position accounts for 0.33% of the portfolio, ranked #73.
Lowe Brockenbrough & Co first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.48M in Q4 2014. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Lowe Brockenbrough & Co held 30,639 shares of AbbVie worth $6.66M as of Q1 2026.
- Lowe Brockenbrough & Co sold 722 AbbVie shares in Q1 2026, an estimated $160K.
- AbbVie made up 0.33% of Lowe Brockenbrough & Co's portfolio in Q1 2026, its #73 holding.
- Lowe Brockenbrough & Co first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Lowe Brockenbrough & Co's AbbVie position peaked at $8.48M in Q4 2014.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Lowe Brockenbrough & Co's 13F filing for Q1 2026, filed 7 May 2026.